Fuji Pharma Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3816200004
JPY
1,729.00
3 (0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Sep'18
Net Sales
46,138.00
40,889.00
35,426.00
33,990.00
33,793.00
36,279.00
37,909.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
46,138.00
40,889.00
35,426.00
33,990.00
33,793.00
36,279.00
37,909.00
Raw Material Cost
29,625.00
25,515.00
21,808.00
19,855.00
19,545.00
21,096.00
22,704.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
196.00
121.00
77.00
53.00
37.00
41.00
38.00
Selling and Distribution Expenses
9,231.00
8,331.00
7,355.00
8,340.00
8,048.00
8,957.00
9,054.00
Other Expenses
320.50
306.30
240.80
239.30
302.30
201.10
172.20
Total Expenditure (Excl Depreciation)
42,257.00
37,030.00
31,648.00
30,641.00
30,653.00
32,105.00
33,518.00
Operating Profit (PBDIT) excl Other Income
3881
3859
3778
3349
3140
4174
4391
Other Income
3,246.00
417.00
309.00
86.00
-184.00
-94.00
118.00
Operating Profit (PBDIT)
10,807.00
7,299.00
6,832.00
5,541.00
5,013.00
6,209.00
6,760.00
Interest
196.00
121.00
77.00
53.00
37.00
41.00
38.00
Exceptional Items
1,345.00
244.00
-287.00
-11.00
0.00
-77.00
0.00
Gross Profit (PBDT)
16,513.00
15,374.00
13,618.00
14,135.00
14,248.00
15,183.00
15,205.00
Depreciation
3,680.00
3,023.00
2,745.00
2,106.00
2,057.00
2,129.00
2,251.00
Profit Before Tax
8,276.00
4,399.00
3,723.00
3,371.00
2,918.00
3,961.00
4,472.00
Tax
2,128.00
963.00
1,026.00
938.00
832.00
998.00
1,099.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6,147.00
3,435.00
2,697.00
2,432.00
2,085.00
2,962.00
3,372.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6,147.00
3,435.00
2,697.00
2,432.00
2,085.00
2,962.00
3,372.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6,147.00
3,435.00
2,697.00
2,432.00
2,085.00
2,962.00
3,372.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
45,560.00
41,175.00
35,804.00
32,680.00
39,959.00
39,361.00
35,348.00
Earnings per share (EPS)
252.81
141.35
110.98
90.52
66.92
97.02
112.67
Diluted Earnings per share
252.81
141.35
110.98
90.52
66.92
97.02
112.67
Operating Profit Margin (Excl OI)
8.41%
9.44%
10.66%
9.85%
9.29%
11.51%
11.58%
Gross Profit Margin
25.91%
18.15%
18.26%
16.11%
14.72%
16.79%
17.73%
PAT Margin
13.32%
8.4%
7.61%
7.16%
6.17%
8.16%
8.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2024 is 12.84% vs 15.42% in Sep 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Sep 2024 is 78.95% vs 27.36% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2024 is 9.87% vs 5.50% in Sep 2023

stock-summary

Interest

YoY Growth in year ended Sep 2024 is 61.98% vs 57.14% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Sep 2024 has fallen from Sep 2023

Compare Annual Results Of Fuji Pharma Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
46,138.00
50,643.00
-4,505.00
-8.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
46,138.00
50,643.00
-4,505.00
-8.90%
Raw Material Cost
29,625.00
42,005.00
-12,380.00
-29.47%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
196.00
123.00
73.00
59.35%
Selling and Distribution Expenses
9,231.00
6,017.00
3,214.00
53.42%
Other Expenses
320.50
-12.30
332.80
2,705.69%
Total Expenditure (Excl Depreciation)
42,257.00
48,022.00
-5,765.00
-12.00%
Operating Profit (PBDIT) excl Other Income
3,881.00
2,621.00
1,260.00
48.07%
Other Income
3,246.00
493.00
2,753.00
558.42%
Operating Profit (PBDIT)
10,807.00
7,446.00
3,361.00
45.14%
Interest
196.00
123.00
73.00
59.35%
Exceptional Items
1,345.00
-33.00
1,378.00
4,175.76%
Gross Profit (PBDT)
16,513.00
8,638.00
7,875.00
91.17%
Depreciation
3,680.00
4,332.00
-652.00
-15.05%
Profit Before Tax
8,276.00
2,958.00
5,318.00
179.78%
Tax
2,128.00
1,192.00
936.00
78.52%
Provisions and contingencies
0
0
0.00
Profit After Tax
6,147.00
1,908.00
4,239.00
222.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
6,147.00
1,908.00
4,239.00
222.17%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-143.00
143.00
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6,147.00
1,765.00
4,382.00
248.27%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
45,560.00
52,003.00
-6,443.00
-12.39%
Earnings per share (EPS)
252.81
62.72
190.09
303.08%
Diluted Earnings per share
252.81
62.72
190.09
303.08%
Operating Profit Margin (Excl OI)
8.41%
5.18%
0.00
3.23%
Gross Profit Margin
25.91%
14.39%
0.00
11.52%
PAT Margin
13.32%
3.77%
0.00
9.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 4,613.80 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 12.84% vs 15.42% in Sep 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 614.70 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 78.95% vs 27.36% in Sep 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 756.10 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 9.87% vs 5.50% in Sep 2023

Annual - Interest
Interest 19.60 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 61.98% vs 57.14% in Sep 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.41%
in Sep 2024

Figures in %
stock-summary

YoY Growth in year ended Sep 2024 has fallen from Sep 2023